Dr. Reddy's launches generic Cymbalta

HYDERABAD, India — Dr. Reddy's Labs on Friday announced the launch of duloxetine delayed-release capsules USP in 20 mg, 30 mg and 60 mg dosage strengths. The drug is the generic version of Cymbalta from Eli Lilly and Co.  

Cymbalta and its generic equivalents had sales in the United States of approximately $5.0 billion for the 12 months ending April 2014, according to IMS Health.